Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants in Children and Adolescents
- 1 November 1996
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 35 (11) , 1491-1501
- https://doi.org/10.1097/00004583-199611000-00018
Abstract
No abstract availableKeywords
Funding Information
- NIMH (MH-01175, MH-31154, MH-47370, MH-40273, MH-40646)
This publication has 65 references indexed in Scilit:
- An Exaggerated Cardiovascular Response to Methylphenidate in ADHD Children with AnxietyJournal of Child and Adolescent Psychopharmacology, 1995
- Postmortem Pharmacokinetics of Tricyclic Antidepressants: Are Some Deaths During Treatment Misattributed to Overdose?Journal of Child and Adolescent Psychopharmacology, 1993
- Model for the Kinetics of Imipramine and Its Metabolites in AdolescentsTherapeutic Drug Monitoring, 1990
- The Physiology and Psychology of Behavioral Inhibition in ChildrenChild Development, 1987
- Cardiovascular effects of desipramine in children and adolescents with attention deficit disorderThe Journal of Pediatrics, 1985
- Ambulatory electrocardiographic monitoring in 100 healthy teenage boys.Heart, 1984
- 24-hour electrocardiographic study of heart rate and rhythm patterns in population of healthy children.Heart, 1981
- The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.Circulation, 1979
- Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptylineLife Sciences, 1979
- A controlled study of imipramine (Tofranil) in the treatment of childhood enuresisThe Journal of Pediatrics, 1965